Analgesic effect of meloxicam Day1 Day2 Case Case Case Case Case Case 1 2 3 4 5 6 Case Case Case Case Case Case 7 8 9 10 11 12 Fi g u r e 1 . Group 1 (treated). Pain scored on a visual analogue scale (VAS) in 6 dogs with acute dermatitis on day one (blue columns), and day 2 (red columns), approximately 24 h after initiating therapy with meloxicam and cephalexin. Fi g u r e 2 . Group 2 (control). Pain scored on a visual analogue scale (VAS) in 6 control dogs with acute dermatitis on day one (blue columns), and day 2 (red columns), approximately 24 h after initiating therapy with saline and cephalexin. Average decrease day 1-2 Meloxicam Placebo Group one n=6 Group two n=6 Fi g u r e 3 . Average decrease in signs of pain scored on VAS from day one to day 2. Change expressed as a percentage. Group 1 was given meloxicam and cephalexin, group 2 was given placebo and cephalexin. Groups compared in Wilcoxon two-sam- ple test p = 0.026. Fi g u r e 5 . Groups 1 and 2. Decrease of painscore on VAS from day one to day 2. Relative decreases shown in percent. Each individual's change is displayed. Groups compared in Wilcoxon two-sample test p = 0.026. 100 ) 90 00 80 -01 70 S 60 VA 50 (e 40 cro 30 sn 20 i aP 10 0 100 90 80 ) 70 00 60 -01 50 ( 40 %30 20 10 0 , 100 e r sco 80 ianp ten 60 f c seo erp 40 era 20 c e 0 D Fi g u r e 4 . Groups 1 and 2. Decrease of painscore on VAS from day one to day 2. Absolute decreases shown in millimetres. Each individual's change is displayed. Groups compared in Wilcoxon two-sam- ple test p = 0.064. 100 ) 90 00 80 1 -0 70 S 60 (VA50 re 40 co 30 s in 20 aP 10 0 mm 50 , reo 40 c s ian 30 p fo 20 e sea 10 r c eD 0 100 2 80 y ad 60 e r sco 40 n i aP 20 0 0 249 Day 1 Day 2 Meloxicam Placebo Meloxicam Placebo 20 40 60 Painscore day 1 80 100 Fi g u r e 6 . Painscore on VAS for all individuals, both groups. Day one is shown on x-axis and day 2 is shown on y-axis. Acta vet. scand. vol. 43 no. 4, 2002